Anatest 100 mg Solution is a Health Canada–registered veterinary drug (DIN 01936158) held by Vetoquinol N A Inc, containing Testosterone Propionate. Health Canada lists its status as Cancelled Post Market (status date 17 Jul 2009). Nexara Health has matched 549 registrations of Testosterone Propionate across 37 other regulated markets.
Health Canada registration
| DIN | 01936158 |
|---|---|
| Brand name | Anatest |
| Active ingredient | Testosterone Propionate |
| Strength | 100 mg |
| Dosage form | Solution |
| Route | Intramuscular |
| Company | Vetoquinol N A Inc |
| Status | Cancelled Post Market — 17 Jul 2009 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Testosterone Propionate registered in other markets
549 registrations of the same molecule in 37 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | AndroForte 5 | Lx | Transdermal cream 50 mg per mL, 50 mL | GE | PBS | |
| Australia | AndroForte 5 | Lx | Transdermal cream 50 mg per mL, 50 mL | GE | PBS | |
| Australia | Rejunon 1000 | Ju | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | GE | PBS | |
| Australia | Testavan | Ix | Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | GE | PBS | |
| Australia | Testavan | Ix | Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | GE | PBS | |
| Australia | Testogel | Hb | Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 | GE | PBS | |
| Australia | Testogel | Hb | Transdermal gel 50 mg in 5 g sachet, 30 | GE | PBS | |
| Australia | Testogel | Hb | Transdermal gel 50 mg in 5 g sachet, 30 | GE | PBS | |
| Austria | Testavan 20 mg/g transdermales Gel | — | 85,5g | yellow box | eEKO (Erstattungskodex) | |
| Austria | Testogel 50 mg Gel Btl. | — | 30St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Testomed 1.000 mg/4 ml Inj.lsg. | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Testosteron "EVER Pharma" 1.000 mg/4 ml Inj.lsg. | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Testosteron "ratiopharm" 1.000 mg/4 ml Inj.lsg. | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Bahrain | Androgel | Besins Healthcare SA, Belgium. | 16.2 MG/G | Gel | POM | NHRA |
| Bolivia | Testosterona undecanoato | — | 1.000 mg | Inyectable | LINAME (formulary) | |
| Bulgaria | Nebido | Grunenthal Pharmaceuticals GmbH & Co.KG, | 250 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Omnadren | Bausch Health Ireland Limited | solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Testosterone Teva | Teva B.V. | 1000 mg/4 ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Croatia | Androgel gel | Besins Healthcare S.A. | vreć. 30x50 mg/5 g | RS | HZZO | |
| Croatia | Nebido | Bayer d.o.o. | otop. za inj., boč.1x1000 mg/4 ml | RS | HZZO | |
| Croatia | testosteron | — | R | HZZO | ||
| Czech Republic | Androgel | — | 16,2MG/G | Tdr Gel | R | SUKL DLP |
| Czech Republic | Nebido | Gr�nenthal Pharmaceuticals GmbH & Co. KG, Leverkusen | 1000MG/4ML | Inj Sol | B | SUKL DLP |
| Czech Republic | Sustanon | — | 250MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Testavan | — | 20MG/G | Tdr Gel | R | SUKL DLP |
| Czech Republic | Testosteron Undekano�T Besins | — | 1000MG/4ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Testosteron Undekano�T Ever Pharma | — | 1000MG/4ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Testosterone Undecanoate Sun | — | 1000MG/4ML | Inj Sol | R | SUKL DLP |
| Denmark | Livensa | Warner Chilcott Deutschland GmbH | 300 mikrog/24 timer | depotplastre | Central | Laegemiddelstyrelsen |
| Denmark | Nebido | 2care4 ApS | 1000 mg/dosis | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Nebido | Grünenthal Pharmaceuticals GmbH & Co. KG | 1000 mg/dosis | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Nebido | Paranova Danmark ApS | 1000 mg/dosis | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Nebido | Ebb Medical AB | 1000 mg/dosis | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Testavan | 2care4 ApS | 20 mg/g | transdermal gel | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Testavan | Epione Medicine ApS | 20 mg/g | transdermal gel | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Testavan | Paranova Danmark ApS | 20 mg/g | transdermal gel | Par-Imp | Laegemiddelstyrelsen |
| Dominican Republic | Testalim Depot | Dutriec S.a. | Registered | MISPAS | ||
| European Union (EMA) | Intrinsa | Warner Chilcott UK Ltd. | Withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Livensa | Warner Chilcott Deutschland GmbH | Withdrawn | EMA centrally authorised | ||
| Finland | Androtopic | Besins Healthcare SA | 16.2 mg/g | geeli | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Atmos | AstraZeneca Oy | 5 mg / 24 tuntia | depotlaastari | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Atmos | AstraZeneca Oy | 2.5 mg / 24 tuntia | depotlaastari | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Intrinsa | Warner Chilcott UK Limited | 300 mikrog / 24 tuntia | depotlaastari | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Livensa | Warner Chilcott Deutschland GmbH | 300 mikrog / 24 tuntia | depotlaastari | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Nebido | Grünenthal Pharmaceuticals GmbH & Co. KG | 1000 mg / 4 ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Panteston | Merck Sharp & Dohme B.V. | 40 mg | kapseli, pehmeä | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Panteston | Paranova Oy | 40 mg | kapseli, pehmeä | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Greece | NEBIDO INJ.SOL 1000MG/4ML BTx1 VIALx4 ML | Grunenthal Pharmaceuticals GmbH & Co. Kg, Germany | reimbursed | MoH deltio timwn | ||
| Greece | Testogel® Trande.gel 16.2mg/g Bt X 1 [Multi Dose (Pp) Container + Δοσομετρικη Αντλια Των 60 Δοσεων/88g] | Laboratoires Besins International, Paris, France | reimbursed | MoH deltio timwn | ||
| Greece | TESTOSTERONE ENANTHATE/NORMA INJ.SOL 250MG/ML BTx1 AMP x1 ML | Νορμα Ελλας Α.ε. | reimbursed | MoH deltio timwn | ||
| Greece | TOSTRAN GEL.EXT.US 2% W/W BTx 1 canister x60 G | Advanz Pharma Limited, Ireland | reimbursed | MoH deltio timwn | ||
| Hong Kong | Androgel Gel 50mg/Sachet | Besins Healthcare China Investments Limited | Registered | DH Drug Office | ||
| Hong Kong | Testosterone Enantate Solution For Injection 250mg/1ml | Dch Auriga (Hong Kong) Limited - Universal Division | Registered | DH Drug Office | ||
| Hong Kong | Testoviron Depot Inj 250mg Im | Bayer Healthcare Limited | Registered | DH Drug Office | ||
| Hungary | Androgel 50 mg Transzdermális Gél Tasakban | Laboratoires Besins International | 30x tasakban ldpe/al/pet egyadagos | NEAK PUPHA | ||
| Hungary | Nebido 250 mg/mL Oldatos Injekció | Grünenthal Pharmaceuticals GmbH & Co. KG | 1x4ml injekciós üvegben | NEAK PUPHA | ||
| Iceland | Depotesto | Williams & Halls ehf | 250 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Nebido | Grünenthal Pharmaceuticals GmbH & Co. K | 250 mg/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Nebido (Heilsa) | Heilsa ehf. | 250 mg/ml | stl | 3 | Lyfjastofnun lyfjaverdskra |
| Iceland | Testogel | Laboratoires Besins International | 16,2 mg/g | hlaup | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Testogel | Laboratoires Besins International | 50 mg | hlaup | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Testogel (Heilsa) | Heilsa ehf. | 50 mg | hlaup | 3 | Lyfjastofnun lyfjaverdskra |
| Iceland | Testosteron Medical Valley | Medical Valley Invest AB | 250 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Testosterone Cypionate | Parlogis - óskráð lyf | 100 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Androgel 50 mg, transdermal gel in sachet | Laboratoires Besins International | Transdermal gel in sachet | Not marketed | HPRA | |
| Ireland | Nebido 1000 mg/4 ml, solution for injection | PCO Manufacturing Ltd. | Solution for injection | Unknown | HPRA | |
| Ireland | Nebido 1000 mg/4 ml, solution for injection | Grunenthal Pharma Limited. | Solution for injection | Marketed | HPRA | |
| Ireland | Testarzon 20 mg/g Transdermal gel | The Simple Pharma Company Limited | Transdermal gel | Marketed | HPRA | |
| Ireland | Testogel 16.2 mg/g, Gel | Laboratoires Besins International | Gel | Marketed | HPRA | |
| Ireland | Testogel 40.5 mg transdermal gel in sachet | Laboratoires Besins International | Transdermal gel in sachet | Marketed | HPRA | |
| Ireland | Testogel 50 mg transdermal gel in sachet | Merit Pharmaceuticals Limited | Transdermal gel in sachet | Unknown | HPRA | |
| Ireland | Testogel 50 mg transdermal gel in sachet | Laboratoires Besins International | Transdermal gel in sachet | Marketed | HPRA | |
| Italy | TESTAVAN*gel 1 contenitore multidose 85,5 g/56 dosi 20 mg/g | The Simple Pharma Company Ltd | TESTOSTERONE 20MG/G 85,5G GEL USO ESTERNO | Classe A | AIFA liste A/H | |
| Italy | TESTOVIS*2 fiale IM 100 mg 2 ml | SIT LABORATORIO FARMAC. Srl | TESTOSTERONE PROPIONATO 100MG 2 UNITA' USO PARENTERALE | Classe A | AIFA liste A/H | |
| Italy | TOSTREX*gel multidose 60 g 20 mg/g con dosatore | Advanz Pharma Limited | TESTOSTERONE 2% 60G GEL USO TRANSDERMICO | Classe A | AIFA liste A/H | |
| Luxembourg | Androgel GEL 16,2 mg / 1 g 1*1 récipient multidose | — | RR | CNS liste positive | ||
| Luxembourg | Nebido SOL.INJ. 1000 mg / 4 mL 1*1 flacon 4 mL | — | RR | CNS liste positive | ||
| Luxembourg | SUSTANON SOL.INJ. 250 mg 1*1 ampoule 1 mL | — | RR | CNS liste positive | ||
| Luxembourg | Testarzon GEL TRANSDERM. 20 mg / 1 g 1*1 récipient multidose | — | RR | CNS liste positive | ||
| Luxembourg | Testosterone Besins SOL.INJ. 1000 mg / 4 mL 1*1 flacon 4 mL | — | RR | CNS liste positive | ||
| MA | Andriol Gm | — | 40 MG | Capsule | P | CNOPS liste des medicaments |
| MA | Andriol Pm | — | 40 MG | Capsule | P | CNOPS liste des medicaments |
| MA | Androtardyl | — | 250 MG | Solution Injectable | P | CNOPS liste des medicaments |
| MA | Sustanon | — | 100 / 60 MG / MG | Solution Injectable | P | CNOPS liste des medicaments |
| Malaysia | Androgel 16.2mg/g, gel (testosterone) | Brego Life Sciences Sdn. Bhd | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malaysia | Androgel 25mg, gel of testosterone 1% | Brego Life Sciences Sdn. Bhd | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malaysia | Nebido 1000mg Solution For Injection | Dksh Malaysia Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malta | Nebido 1000 mg/4ml solution for injection | NeoFarma Pharmaceuticals Limited | Solution For Injection | Authorised | Medicines Authority | |
| Malta | Restandol Testocaps 40mg capsule, soft | Merck Sharp & Dohme Limited | Soft Capsule | Withdrawn | Medicines Authority | |
| Malta | Testim 50mg Gel | Ferring Pharmaceuticals Limited | Gel | Withdrawn | Medicines Authority | |
| Malta | Testosterone EVER Pharma 1000 mg/4 ml solution for injection | EJ Busuttil Ltd | Solution For Injection | Authorised | Medicines Authority | |
| Netherlands | Androgel 16,2 mg/g, gel | Besins Healthcare Netherlands B.V. | Gel | Uitsluitend recept | EU national register | |
| Netherlands | Androgel 16,2 mg/g, gel | Euro Registratie Collectief B.V. | Gel | Uitsluitend recept | EU national register | |
| Netherlands | Androgel 16,2 mg/g, gel | Medcor Pharmaceuticals B.V. | Gel | Uitsluitend recept | EU national register | |
| Netherlands | Androgel 25 mg, gel voor transdermaal gebruik in sachet | Besins Healthcare Netherlands B.V. | Gel voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Androgel 40,5 mg, gel voor transdermaal gebruik in sachet | Besins Healthcare Netherlands B.V. | Gel voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Androgel 50 mg, gel in sachet | Euro Registratie Collectief B.V. | Gel | Uitsluitend recept | EU national register | |
| Netherlands | Androgel 50 mg, gel voor transdermaal gebruik in sachet | Besins Healthcare Netherlands B.V. | Gel voor transdermaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Nebido 1000 mg/4 ml, oplossing voor injectie | BModesto B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Norway | Nebido inj, oppl 1000 mg/4 ml | Grünenthal Pharmaceuticals GmbH & Co. KG | 4 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Taro-Testosterone kaps 40 mg | Taro Pharmaceuticals | 120 | Kapsel, myk | Aktiv oppføring | FEST (DMP) |
| Norway | Taro-Testosterone kaps 40 mg | Taro Pharmaceuticals | 60 | Kapsel, myk | Aktiv oppføring | FEST (DMP) |
| Norway | Testavan transdermalgel 20 mg/g | The Simple Pharma Company Limited | 85.5 | Transdermalgel | Aktiv oppføring | FEST (DMP) |
| Norway | Testavan transdermalgel 20 mg/g | The Simple Pharma Company Limited | 85.5 | Transdermalgel | Aktiv oppføring | FEST (DMP) |
| Norway | Testavan transdermalgel 20 mg/g | The Simple Pharma Company Limited | 3 x 85.5 | Transdermalgel | Aktiv oppføring | FEST (DMP) |
| Norway | Testogel transdermalgel 50 mg/5 g | Laboratoires Besins International | 30 x 5 | Transdermalgel | Aktiv oppføring | FEST (DMP) |
| Norway | Testosteron Depot panpharma inj, oppl 250 mg/ml | Panpharma | 3 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Poland | Androtop | Besins Healthcare S.A. | 16,2 mg/g | Żel przezskórny | Bezterminowe | URPL RPL |
| Poland | Androtop | Laboratoires Besins International | 50 mg/5 g | Żel przezskórny | 2023-10-09 | URPL RPL |
| Poland | Androtop | Laboratoires Besins International | 25 mg/2,5 g | Żel przezskórny | 2023-10-09 | URPL RPL |
| Poland | Nebido | Grünenthal Pharmaceuticals GmbH & Co. KG | 1000 mg/4 ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Nebido | Delfarma Sp. z o.o. | 1000 mg/4 ml | Roztwór do wstrzykiwań | 2031-05-18 | URPL RPL |
| Poland | Seltigex | Exeltis Poland Sp. z o.o. | 16,2 mg/g | Żel przezskórny | 2031-07-14 | URPL RPL |
| Poland | Testavan | The Simple Pharma Company Limited | 20 mg/g | Żel przezskórny | Bezterminowe | URPL RPL |
| Poland | Testosterone enantate EVER Pharma | EVER Valinject GmbH | 250 mg/ml | Roztwór do wstrzykiwań | 2030-04-01 | URPL RPL |
| Romania | ANDROGEL 16,2 mg/g | — | 16,2mg/g | Gel Transdermic | PRF | ANMDMR nomenclator |
| Romania | ANDROGEL 16,2 mg/g | — | 16,2mg/g | Gel Transdermic | PRF | ANMDMR nomenclator |
| Romania | ANDROGEL 16,2 mg/g | — | 16,2mg/g | Gel Transdermic | PRF | ANMDMR nomenclator |
| Romania | NEBIDO 1000 mg/4 ml | — | 1000mg/4ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | TESTOSTERON EVER PHARMA 1000 mg/4 ml | — | 1000mg/4ml | Sol. Inj. | PR _x0002_ | ANMDMR nomenclator |
See every manufacturer of Testosterone Propionate worldwide →
Regulator price references for Testosterone Propionate
Published list or reimbursement prices for Testosterone Propionate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Testogel | Transdermal gel 50 mg in 5 g sachet, 30 | 60.92 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Testogel | Transdermal gel 50 mg in 5 g sachet, 30 | 60.92 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Testogel | Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 | 60.92 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Testogel | Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 | 60.92 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Testavan | Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | 65.99 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Testavan | Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | 65.99 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Rejunon 1000 | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | 75.31 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | AndroForte 5 | Transdermal cream 50 mg per mL, 50 mL | 87.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | AndroForte 5 | Transdermal cream 50 mg per mL, 50 mL | 87.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Testavan 20 mg/g transdermales Gel | 85500mg | 85,5g | 43.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Testomed 1.000 mg/4 ml Inj.lsg. | 1mg/4ml | 1St | 45.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Testosteron "ratiopharm" 1.000 mg/4 ml Inj.lsg. | 1mg/4ml | 1St | 45.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Testosteron "EVER Pharma" 1.000 mg/4 ml Inj.lsg. | 1mg/4ml | 1St | 45.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Testogel 50 mg Gel Btl. | 50mg | 30St | 53.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Androgel | 16.2mg/1000mg | 1 X 88G | 26.47 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | TESTOSTERONE ENANTHATE/NORMA INJ.SOL 250MG/ML BTx1 AMP x1 ML | 250mg/1ml | 12.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | TOSTRAN GEL.EXT.US 2% W/W BTx 1 canister x60 G | 2pct+60000mg | 24.59 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Testogel® Trande.gel 16.2mg/g Bt X 1 [Multi Dose (Pp) Container + Δοσομετρικη Αντλια Των 60 Δοσεων/88g] | 16.2mg/1000mg | 39.33 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | NEBIDO INJ.SOL 1000MG/4ML BTx1 VIALx4 ML | 1000mg/4ml | 74.25 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Androgel 50 mg Transzdermális Gél Tasakban | 50mg | 30x tasakban ldpe/al/pet egyadagos | 9,822.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Nebido 250 mg/mL Oldatos Injekció | 4ml | 1x4ml injekciós üvegben | 23,652.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Testoviron Depot | 250mg/1ml | áfspr | 3,948.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testogel | 50mg | pakki | 4,951.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testogel (Heilsa) | 50mg | pakki | 5,236.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testogel | 16.2mg/1000mg | ílát | 5,269.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Tostrex | 2pct | pakki | 6,022.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Depotesto | 250mg/1ml | hgl | 9,829.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testoviron Depot | 250mg/1ml | lykjur | 12,083.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testosteron Medical Valley | 250mg/1ml | hgl | 12,140.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testosterone Teva | 250mg/1ml | hgl | 13,187.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Nebido | 250mg/1ml | hgl | 13,664.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Nebido (Heilsa) | 250mg/1ml | hgl | 13,732.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testosterone Cypionate | 200mg/1ml | hgl | 13,889.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Testosterone Cypionate | 100mg/1ml | hgl | 19,541.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Italy | TESTOVIS*2 fiale IM 100 mg 2 ml | 100mg | TESTOSTERONE PROPIONATO 100MG 2 UNITA' USO PARENTERALE | 3.99 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Italy | TESTAVAN*gel 1 contenitore multidose 85,5 g/56 dosi 20 mg/g | 20mg/1000mg | TESTOSTERONE 20MG/G 85,5G GEL USO ESTERNO | 48.04 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Italy | TOSTREX*gel multidose 60 g 20 mg/g con dosatore | 2pct+60000mg | TESTOSTERONE 2% 60G GEL USO TRANSDERMICO | 50.80 EUR | prezzo al pubblico (classe A) | AIFA liste A/H | 2026-09-02 |
| Luxembourg | SUSTANON SOL.INJ. 250 mg 1*1 ampoule 1 mL | 1ml+250mg | 11.34 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Testarzon GEL TRANSDERM. 20 mg / 1 g 1*1 récipient multidose | 20mg/1000mg | 49.71 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Androgel GEL 16,2 mg / 1 g 1*1 récipient multidose | 16.2mg/1000mg | 58.11 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Testosterone Besins SOL.INJ. 1000 mg / 4 mL 1*1 flacon 4 mL | 1000mg/4ml | 71.71 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Nebido SOL.INJ. 1000 mg / 4 mL 1*1 flacon 4 mL | 1000mg/4ml | 112.91 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| MA | Androtardyl | 250mg | 1 BOITE 1 AMPOULE | 40.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Sustanon | 60mg/1mg | 1 BOITE 1 AMPOULE INJECTABLE | 45.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Andriol Pm | 40mg | 1 BOITE 20 COMPRIME | 75.60 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Andriol Gm | 40mg | 1 BOITE 60 COMPRIME | 190.20 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| Norway | Tostran | 20mg/1000mg | 60 g | 466.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Testogel | 50mg/5000mg | 5 g | 528.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Testavan | 20mg/1000mg | 85.5 g, stk | 628.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Testavan | 20mg/1000mg | 85.5 g | 628.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Tozaron | 1000mg/4ml | 4 ml | 1,361.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Nebido | 1000mg/4ml | 4 ml | 1,361.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Testosteronundekanoat Medical Valley | 1000mg/4ml | 4 ml | 1,361.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Testavan | 20mg/1000mg | 85.5 g | 1,811.80 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Testoviron Depot 250mg-1ml Amp | 1ml+250mg | 26.25 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Axelus | 26.25 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Andriol Testocaps 40mg | 40mg | 90.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Androgel | 205.15 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Testavan | 213.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Androgel 1% Gel | 1pct | 232.65 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Nebido 1000 mg- 4 mL Solution For Inj | 1000mg+4ml | 322.05 SAR | public | SFDA | 2026-09-01 | |
| Slovakia | Sterovid 1000 mg/4 ml injekčný roztok | 1000mg+4ml | sol inj 1x4 ml/1000 mg (liek.inj.skl.hnedá) | 42.72 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | Testosterón-undekanoát EVER Pharma 1000 mg/4 ml injekčný roztok | 1000mg+4ml | sol inj 1x4 ml/1000 mg (liek.inj.skl.jantár.) | 42.72 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | Nebido 1000 mg/4 ml injekčný roztok | 1000mg+4ml | sol inj 1x4 ml/1000 mg (liek.skl.hnedá.) | 70.34 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| South Africa | Androxon | 40mg | 60 | 687.75 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Androgel | 50mg/5000mg | 30 | 760.79 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Testosterone Cipla | 1000mg/4ml | 4 | 1,947.00 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Testosterone PD | 1000mg/4ml | 4 | 2,060.80 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Nebido | 1000mg/4ml | 4 | 2,290.26 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | TestaForte | 50mg/1ml | 50 | 2,380.49 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | TestaFeme | 10mg/1ml | 50 | 2,380.49 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| Sweden | Testosteron Medical Valley | 1000mg/4ml | 4.00000 Injektionsvätska | 457.68 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| Sweden | Testonur | 1000mg/4ml | 4.00000 Injektionsvätska | 459.99 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| Sweden | Testosterone SUN | 1000mg/4ml | 4.00000 Injektionsvätska | 480.00 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| Sweden | Testosterone Teva | 1000mg/4ml | 4.00000 Injektionsvätska | 1,039.02 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| Sweden | Testosterone Orifarm | 1000mg/4ml | 4.00000 Injektionsvätska | 1,045.00 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| Sweden | Nebido® | 1000mg/4ml | 4.00000 Injektionsvätska | 1,045.40 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| Sweden | Nebido | 1000mg/4ml | 4.00000 Injektionsvätska | 1,045.41 SEK | AIP (pharmacy purchase price) | TLV periodens varor | 2026-09-03 |
| United Arab Emirates | Testeriol 750mg / 3ml | 750mg/3ml | 1 Glass Vial (3ml) | 115.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | TESTAVAN® 20 mg/g | 20mg/1000mg | Transdermal Gel (85.5 g) in 56 Metered Dose Pump + Applicator | 235.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Anatest (DIN 01936158) marketed in Canada?
No. Health Canada lists DIN 01936158 as Cancelled Post Market as of 17 Jul 2009.
Who holds the Canadian licence for this product?
Vetoquinol N A Inc is the company of record in the Health Canada Drug Product Database.
Is Testosterone Propionate registered outside Canada?
Yes — Nexara Health has matched 549 registrations in 37 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01936158, status date 2009-07-17; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP, URPL RPL; price sources: AIFA liste A/H, CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA, TLV periodens varor. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01936158, status date 2009-07-17; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP, URPL RPL; price sources: AIFA liste A/H, CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA, TLV periodens varor.
Vetoquinol N A Inc — company profileWho else makes Testosterone PropionateAll Canadian Testosterone Propionate products
Health Canada Drug Product Database (DPD), DIN 01936158, status date 2009-07-17; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP, URPL RPL; price sources: AIFA liste A/H, CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA, TLV periodens varor. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.